Transcatheter closure of atrial septal defects type 2 in children under three years of age

Knop, Mateusz; Białkowski, Jacek; Szkutnik, Małgorzata; Fiszer, Roland; Smerdziński, Sebastian; Gałeczka, Michał; Litwin, Linda

doi:10.5603/kp.a2018.0113

Cited by 19 publications

(32 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…According to the present study, transcatheter or intraoperative device closure of ASDs is feasible and effective in infants under 3 years of age. Studies on ASD closure in infants mostly involved the results on transcatheter closure [4,9,16]. Transcatheter closure has been the first choice in the treatment of secundum ASD with appropriate morphology [8].…”

Section: Discussionmentioning

confidence: 99%

Transcatheter and intraoperative device closure of atrial septal defect in infants under three years of age

Han¹,

Zhang²,

Zhang³

2020

J Cardiothorac Surg

View full text Add to dashboard Cite

Background: Transcatheter and intraoperative device closures have been widely used in the treatment of secundum atrial septal defect (ASD). However, for young infants with ASD, device closure remains controversial, and such treatment features limited data. We compared the clinical data and follow-up results of percutaneous and intraoperative device closure for ASD to evaluate the feasibility, safety, and efficacy of both treatments in infants under 3 years of age. Methods: From September 2010 to September 2018, 186 children under 3 years of age with significant secundum ASD were included in this study. A total of 88 and 98 patients were divided into groups A (transcatheter device closure) and B (intraoperative device closure), respectively. The clinical data and follow-up results of the two groups were analyzed retrospectively. Result: The mean age and weight of patients in group A were significantly higher than those in group B. The proportion of complex ASDs (multiples or rims deficiency) and the device/weight ratio in group B were significantly higher than those in group A. Successful closure was obtained in 86 (97.7%) and 96 (98.0%) infants in groups A and B, respectively, with two failed cases in each group (2.3% vs 2%). The rate of periprocedural complications reached 13.6 and 26.5% for groups A and B (P = 0.058), respectively. The durations of the procedure and postoperative hospital stay in group A were significantly shorter than those in group B (P < 0.05). Excellent follow-up results were observed in both groups. At present, no death nor major complications have occurred. Symptoms either resolved completely or improved significantly for all symptomatic infants. No residual shunts at the 6th month of follow-up evaluation were observed. Patients with failure to thrive gained weight appropriately for age, and the structure and hemodynamic parameters significantly improved during follow-up. Conclusion: Transcatheter and intraoperative device closure are feasible, effective, and safe methods for the treatment of ASDs in infants under 3 years of age. Considering improved cosmetic effect and the short duration of the procedure and postoperative hospital stay, transcatheter is preferred for patients with appropriate conditions. Intraoperative device closure can be performed as an alternative to percutaneous closure, particularly for infants with large, complex ASDs, young age, or low-body weight.

show abstract

Section: Discussionmentioning

confidence: 99%

Transcatheter and intraoperative device closure of atrial septal defect in infants under three years of age

Han¹,

Zhang²,

Zhang³

2020

J Cardiothorac Surg

View full text Add to dashboard Cite

show abstract

“…generally 2-3 F larger than those of the ASO is less important in adults than in preschool chil dren. 1,5 The rates of periprocedural complications and procedural difficulties (reflected in the fluo roscopic time) were similar in both groups (TABLE 1).…”

mentioning

confidence: 82%

“…Introduction Transcatheter closure of atri al septal defect (ASD) type II can be safely per formed in children and adults. 1,2 Since the im plementation of the Amplatzer septal occluder (ASO) in 1997, many similar nitinol wire mesh Amplatzer like occluders have been developed. Nitinol is an alloy of nickel and titanium.…”

mentioning

confidence: 99%

Transcatheter closure of atrial septal defect with Chinese and Thai nitinol wire mesh occluders in adult patients

et al. 2020

Self Cite

View full text Add to dashboard Cite

“…106 There is a natural tendency toward closing ASDs in more challenging clinical scenarios and larger defects in smaller patients. Lim et al 107 conducted an effective percutaneous ASD closure in a 2.8-kg preterm newborn. 107 There are numerous accounts of ASD closure in infants and very small children.…”

Section: Short Review Of the Devices Available Inmentioning

confidence: 99%

Percutaneous closure of atrial septal defect: a consensus document of the joint group of experts from the Association of Cardiovascular Interventions and the Grown-Up Congenital Heart Disease Section of the Polish Cardiac Society

et al. 2020

Self Cite

View full text Add to dashboard Cite

communication. There are 5 types of anatomic defects known: • Secundum ASD (ASD II): 80% to even more than 90% of ASDs in the adult population; located in the fossa ovalis region and its surrounding tissue. Background information on atrial septal defect Atrial septal defect (ASD) is one of the most prevalent congenital heart defects and may frequently remain undiagnosed until adulthood. 1-4 It is a consequence of various embryological disorders that cause interatrial

show abstract

Transcatheter closure of atrial septal defects type 2 in children under three years of age

Abstract: Percutaneous ASD closure can be performed safely in children under three years of age with low risk of peri- or postprocedural complications.

Cited by 19 publications

References 0 publications

Transcatheter and intraoperative device closure of atrial septal defect in infants under three years of age

Transcatheter and intraoperative device closure of atrial septal defect in infants under three years of age

Transcatheter closure of atrial septal defect with Chinese and Thai nitinol wire mesh occluders in adult patients

Percutaneous closure of atrial septal defect: a consensus document of the joint group of experts from the Association of Cardiovascular Interventions and the Grown-Up Congenital Heart Disease Section of the Polish Cardiac Society

Contact Info

Product

Resources

About